Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data

2022
Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes M, Switchenko J, Scagliotti G, Higgins K, Tsao M, Belani C, Sequist L, Ramalingam SS
Read more